| 7:00
a.m. |
Registration
and Continental Breakfast
|
| 8:00
a.m. |
|
Welcome
and Introduction
|
| |
|
Molly Joel Coye, M.D., M.P.H.
Senior Vice President
The Lewin Group
San Francisco, CA
|
| |
|
Peter N. Grant, J.D., Ph.D.
Partner
Davis Wright Tremaine LLP
Seattle, WA and San Francisco, CA
|
| |
|
(Congress Co-Chairs)
|
| 8:00
a.m. |
|
Panel Discussion and Presentations Regarding the Future of Pharmaceuticals
in Medical Care
|
|
|
The Implications of Medical Research and Clinical Innovations
William B. Schwartz, M.D.
Professor of Medicine, University of Southern California
and Author of Life Without Disease: The Pursuit of Medical Utopia
Los Angeles, CA
|
| |
|
Opportunity and Challenges of Rapid Pharmaceutical Innovation
Karen Williams
President, National Pharmaceutical Council
Reston, VA
|
|
|
Policy and Political Considerations in Extending Drug Benefit
Coverage
Daniel Mendelson
Associate Director for Health and Personnel Office of Management and
Budget
Washington, D.C.
|
| |
|
Pharmaceutical Industry Structure and Relationships
Paul A. Brooke
Managing Director, Tiger Management LLC
New York, NY
|
| 10:30
a.m. |
|
BREAK
Back to Top
|
| 11:00
a.m. |
|
Concurrent
Sessions
Click here
for session details >>
|
12
noon
|
|
Luncheon
and Presentation
|
| |
|
Press Coverage of the Pharmaceutical Enterprise
|
| |
|
Robert Bazell
Chief Science Correspondent
NBC News and Author of Her-2: The Making of
Herceptin, a Revolutionary Treatment for
Breast Cancer
New York, NY
|
| |
|
Jerome P. Kassirer, M.D.
Editor-in-Chief, New England Journal of Medicine
Boston, MA
|
| |
|
Ron
Winslow
Health & Medicine Reporter
Wall Street Journal
New York, NY |
| |
|
John K. Iglehart
Founding Editor, Health Affairs Journal
Project Hope
Bethesda, MD
(Moderator)
|
| 1:30
p.m. |
|
The Economic Implications of Medicare Coverage of Outpatient
Pharmaceuticals
|
| |
|
Stuart
Altman, Ph.D.
Sol C. Chaikin Professor of National Health Policy Institute of Health
Policy, Heller Graduate School,
Brandeis University
Waltham, MA
|
| 2:15
p.m. |
|
The Economics of Pharmaceutical Production, Sales and Use
|
|
|
Robert Rubin, M.D.
President
The Lewin Group
Washington, D.C.
|
| 3:00
p.m. |
|
Break
|
| 3:30
p.m. |
|
Concurrent Sessions
Click here
for session details >>
|
| 4:30
p.m. |
|
Transition
Break
|
| 4:45
p.m. |
|
Concurrent
Sessions
Click here
for session details >>
|
| 5:45
p.m. |
|
Adjournment
|
| 6:15
p.m. |
|
Networking
Reception
|
